Original drugs approved by the Food and Drug Administration (Center for Drug Evaluation and Research) in 2024
The U.S. Food and Drug Administration (FDA), in particular the Center for Drug Evaluation and Research (CDER), plays a key role in ensuring the safety, efficacy, and innovation of medicines entering the U.S. market, and then the world. The annual review of new medicines approved by the FDA is an imp...
Saved in:
Main Authors: | D. V. Kurkin, N. A. Osadchenko, A. R. Makarova, D. A. Galkina, D. A. Bakulin, O. V. Shatalova, A. V. Strygin, V. I. Petrov, O. V. Marincheva, Yu. V. Gorbunova, Yu. A. Kolosov, A. V. Zaborovsky, D. V. Yunina, K. N. Koryanova, E. I. Morkovin, M. A. Dzhavakhyan, V. I. Zvereva, R. V. Drai, I. E. Makarenko, A. S. Shuvaeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute
2025-07-01
|
Series: | Фармация и фармакология (Пятигорск) |
Subjects: | |
Online Access: | https://www.pharmpharm.ru/jour/article/view/1671 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overview of drugs approved by the FDA in 2022
by: D. V. Kurkin, et al.
Published: (2023-11-01) -
The investigation of kinetics dissolution of prolonged indapamide drugs in biorelevant media
by: E. Yu. Sannikova, et al.
Published: (2013-03-01) -
Dynamics of turnover of sugar-lowering drugs in the retail segment of the pharmaceutical market from 2020 to 2024
by: D. V. Kurkin, et al.
Published: (2025-07-01) -
Features of intellectual property protection mechanisms on the example of orphan drugs circulation
by: D. S. Yurochkin, et al.
Published: (2022-01-01) -
GLOBAL PHARMACEUTICAL MARKET TRENDS: OPPORTUNITIES FOR DEVELOPMENT
by: D. A. Demidyonok, et al.
Published: (2019-01-01)